Arezoo Aghakhani

1.7k total citations
94 papers, 1.4k citations indexed

About

Arezoo Aghakhani is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Arezoo Aghakhani has authored 94 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Epidemiology, 49 papers in Hepatology and 21 papers in Infectious Diseases. Recurrent topics in Arezoo Aghakhani's work include Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (44 papers) and Hepatitis Viruses Studies and Epidemiology (20 papers). Arezoo Aghakhani is often cited by papers focused on Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (44 papers) and Hepatitis Viruses Studies and Epidemiology (20 papers). Arezoo Aghakhani collaborates with scholars based in Iran, United States and Bangladesh. Arezoo Aghakhani's co-authors include Amitis Ramezani, Mohammad Banifazl, Ali Eslamifar, Ali Akbar Velayati, Masoomeh Sofian, Fakher Rahim, R Hamkar, Effat Razeghi, Minoo Mohraz and Minoo Mohraz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and AIDS.

In The Last Decade

Arezoo Aghakhani

93 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arezoo Aghakhani Iran 20 960 706 269 202 103 94 1.4k
Mohammad Banifazl Iran 20 914 1.0× 682 1.0× 363 1.3× 189 0.9× 66 0.6× 97 1.3k
Amitis Ramezani Iran 22 1.1k 1.1× 734 1.0× 530 2.0× 203 1.0× 146 1.4× 139 1.7k
Francisco José Dutra Souto Brazil 25 979 1.0× 1.1k 1.6× 487 1.8× 51 0.3× 34 0.3× 87 1.6k
Antonio Rivero‐Juárez Spain 23 754 0.8× 1.5k 2.1× 919 3.4× 151 0.7× 95 0.9× 172 1.9k
Karl–Heinz Herbinger Germany 20 484 0.5× 93 0.1× 494 1.8× 199 1.0× 106 1.0× 47 1.1k
Roberto Bruni Italy 21 375 0.4× 801 1.1× 639 2.4× 51 0.3× 20 0.2× 83 1.2k
L.J. van Doorn Netherlands 26 676 0.7× 429 0.6× 409 1.5× 325 1.6× 34 0.3× 47 2.0k
Paola Chionne Italy 25 1.1k 1.1× 1.2k 1.7× 420 1.6× 34 0.2× 19 0.2× 60 1.8k
Ana Avellón Spain 23 697 0.7× 910 1.3× 755 2.8× 61 0.3× 155 1.5× 65 1.5k
Francis J. Mahoney United States 16 744 0.8× 504 0.7× 163 0.6× 122 0.6× 11 0.1× 22 976

Countries citing papers authored by Arezoo Aghakhani

Since Specialization
Citations

This map shows the geographic impact of Arezoo Aghakhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezoo Aghakhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezoo Aghakhani more than expected).

Fields of papers citing papers by Arezoo Aghakhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arezoo Aghakhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezoo Aghakhani. The network helps show where Arezoo Aghakhani may publish in the future.

Co-authorship network of co-authors of Arezoo Aghakhani

This figure shows the co-authorship network connecting the top 25 collaborators of Arezoo Aghakhani. A scholar is included among the top collaborators of Arezoo Aghakhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arezoo Aghakhani. Arezoo Aghakhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aghakhani, Arezoo, et al.. (2019). Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women. BMC Infectious Diseases. 19(1). 142–142. 13 indexed citations
2.
Sharif, Alireza, Arezoo Aghakhani, Ali Akbar Velayati, et al.. (2016). Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients. Intervirology. 59(3). 179–185. 11 indexed citations
3.
Sharifi, Guive, et al.. (2014). Bilateral Orbital Metastasis of Follicular Thyroid Carcinoma: a Rare Case Report. Iranian journal of pathology. 9(3). 229–233. 2 indexed citations
4.
Sofian, Masoomeh, Arezoo Aghakhani, Mohammad Reza Sharif, et al.. (2013). Screening of family members of patients with acute brucellosis in an endemic area of Iran. SHILAP Revista de lepidopterología. 8 indexed citations
5.
Ramezani, Amitis, Mohammad Banifazl, & Arezoo Aghakhani. (2013). GB Virus C Overview: Insights into Clinical Implication. Journal of Gastroenterology and Hepatology Research. 2(1). 343–349. 1 indexed citations
6.
Aghakhani, Arezoo, Mohammad Banifazl, Ali Akbar Velayati, Ali Eslamifar, & Amitis Ramezani. (2012). Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for Consideration. Therapeutic Apheresis and Dialysis. 16(4). 328–333. 16 indexed citations
7.
Ramezani, Amitis, Mohammad Banifazl, & Arezoo Aghakhani. (2011). Occult hepatitis B infection in chronic hemodialysis patients: Comparison of results and concepts. Hepatitis Monthly. 11(231). 128–129. 4 indexed citations
8.
Ramezani, Amitis, Mohammad Banifazl, Minoo Mohraz, Mehrnaz Rasoolinejad, & Arezoo Aghakhani. (2011). Occult hepatitis B virus infection: A major concern in HIV-infected patients. Hepatitis Monthly. 11(130). 7–10. 36 indexed citations
9.
Sofian, Masoomeh, Arezoo Aghakhani, Aliasghar Farazi, et al.. (2010). Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: Implications for health policy. Travel Medicine and Infectious Disease. 8(3). 176–179. 19 indexed citations
10.
Aghakhani, Arezoo, R Hamkar, Mahmoud Parvin, et al.. (2010). The role of human papillomavirus Infection in prostate carcinoma. International Journal of Infectious Diseases. 14. e468–e468. 3 indexed citations
11.
Farazi, Aliasghar, et al.. (2010). Prevalence of isolated hepatitis B core antibody among injection drug users in Central Province of Iran. International Journal of Infectious Diseases. 14. e226–e227.
12.
Khalili, Hamed, et al.. (2010). Predictive value and cut off point of PPD in probable patients with pulmonary tuberculosis. International Journal of Infectious Diseases. 14. e304–e304. 3 indexed citations
13.
Ramezani, Amitis, Mohammad Banifazl, Ali Eslamifar, & Arezoo Aghakhani. (2010). Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. The Journal of Infection in Developing Countries. 4(10). 658–661. 42 indexed citations
14.
Ramezani, Amitis, Minoo Mohraz, Mohammad Banifazl, et al.. (2009). Prevalence of Dyslipidemia and Metabolic Abnormalities in HIV-Infected Patients. SHILAP Revista de lepidopterología. 47(2). 83–88. 6 indexed citations
15.
Ramezani, Amitis, Arezoo Aghakhani, Fakher Rahim, et al.. (2009). ASSOCIATION BETWEEN HEPATITIS B VIRUS INFECTION OUTCOME AND HLA-A AND DRB1 GENOTYPING IN NORTH PART OF IRAN. Iranian journal of pathology. 4(2). 71–74. 2 indexed citations
16.
Sofian, Masoomeh, Arezoo Aghakhani, Mohammad Banifazl, et al.. (2009). Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. International Journal of Infectious Diseases. 14(4). e308–e310. 42 indexed citations
17.
Kariminia, Amina, Arezoo Aghakhani, Mohammad Banifazl, et al.. (2009). Comparison of QuantiFERON TB‐G‐test to TST for detecting latent tuberculosis infection in a high‐incidence area containing BCG‐vaccinated population. Journal of Evaluation in Clinical Practice. 15(1). 148–151. 18 indexed citations
18.
Eslamifar, Ali, et al.. (2008). FREQUENCY AND IDENTIFICATION OF FUNGAL STRAINS IN PATIENTS WITH CHRONIC RHINOSINUSITIS. Iranian journal of pathology. 3(3). 135–139. 2 indexed citations
19.
Ramezani, Amitis, Ali Akbar Velayati, Latif Gachkar, et al.. (2008). Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection. International Journal of Infectious Diseases. 12(3). 252–255. 10 indexed citations
20.
Aghakhani, Arezoo, et al.. (2007). Risk factors for human brucellosis in Iran: a case–control study. International Journal of Infectious Diseases. 12(2). 157–161. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Banifazl Breakdown of academic impact, for papers by Amitis Ramezani Breakdown of academic impact, for papers by Francisco José Dutra Souto Breakdown of academic impact, for papers by Antonio Rivero‐Juárez Breakdown of academic impact, for papers by Karl–Heinz Herbinger Breakdown of academic impact, for papers by Roberto Bruni Breakdown of academic impact, for papers by L.J. van Doorn Breakdown of academic impact, for papers by Paola Chionne Breakdown of academic impact, for papers by Ana Avellón Breakdown of academic impact, for papers by Francis J. Mahoney
Rankless by CCL
2026